Skip to main content

BioPharma Credit

data as at: 12/08/2020
Company website
Daily factsheet
ObjectiveTo generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Management groupPharmakon Advisors
AIC sectorDebt - Direct Lending
Launch date27/03/2017
Financial year endDecember
DomicileUnited Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Dividends

Dividends displayed in traded currency.

Ex-Dividend DateDividend amountDividend typeSpecial dividendFinancial year
20/08/20200.018IncomeNo2020
21/05/20200.018IncomeNo2020
27/02/20200.018IncomeNo2019
27/02/20200.013CapitalYes2019
14/11/20190.018IncomeNo2019
View dividend history
Dividend cover (years)Revenue reserves (m)
0.4341.69

Trading information

ISINTIDMTraded currency
GB00BDGKMY29BPCRUSD

Traded volumes (number of shares)

Yesterday1 month1 year5 years
Total890,10831,640,353284,697,6600
AverageN/A1,375,6701,120,8600

Traded values (m)

Yesterday1 month1 year5 years
Total0.9131.92280.050.00
AverageN/A1.391.100.00

Data provided by Morningstar. Company documents provided by FE fundinfo. 

Company announcements

Company documents